Clinical trial
Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
NCT00001958 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00001958 |
|---|---|
| Title | Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia) |
| Official title | Effect of Hydroxyurea on the Level of Ineffective Erythropoiesis, Transfusion Requirement, and Fetal Hemoglobin Synthesis in Patients With Beta-Thalassemia-Intermedia |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Beta Thalassemia, Hemoglobinopathy |
| Intervention type | Drug |
| Interventions | Hydroxyurea |
| Enrollment | 100 |
| Start date | Dec 1, 1999 |
| Completion | Feb 1, 2002 |
| First posted | Jan 19, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: